Methods for treating Parkinson's disease

Patent Number: 9387212

Patent Date: 2016-07-12

Patent type: utility

The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A<sub>2A</sub>) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.

Inventors

First Name Last Name City State Country
Bernard Christophe - - -
Dieter Scheller - - -
Anne Michel - - -
Patrick Downey - - -
Florian Montel - - -

IPCs

Section Class Sub Class Group Sub Group
A 61 K 31 5377
A 61 K 31 195
A 61 K 31 198
A 61 K 31 445
A 61 K 31 451
A 61 K 31 495
A 61 K 31 497
A 61 K 31 501
A 61 K 31 506
A 61 K 31 519
A 61 K 31 52
A 61 K 31 423
A 61 K 31 5415
A 61 K 45 06
A 61 K 31 454

Assignee

Organization First Name Last Name City State Country
UCB Biopharma SPRL - - - - -